Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 4, 2013

ADMA, Allegro, Biothera, Merck, Sagent, Silvergate, UCB

Phase II
Allegro begins vitreomacular traction trial . . . read more

Biothera NSCLC treatment hits primary endpoint . . . read more

Phase III
ADMA Bio completes enrollment for PIDD trial . . . read more

Merck HPV vax improves on Gardasil . . . read more

Filings
USB submits Vimpat sNDA . . . read more

Launches
Sagent launches Carboplatin Injection . . . read more

Silvergate launches Epaned for hypertension . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters